7 research outputs found
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
Document recommendation systems for locating relevant literature have mostly relied on methods developed a decade ago. This is largely due to the lack of a large offline gold-standard benchmark of relevant documents that cover a variety of research fields such that newly developed literature search techniques can be compared, improved and translated into practice. To overcome this bottleneck, we have established the RElevant LIterature SearcH consortium consisting of more than 1500 scientists from 84 countries, who have collectively annotated the relevance of over 180 000 PubMed-listed articles with regard to their respective seed (input) article/s. The majority of annotations were contributed by highly experienced, original authors of the seed articles. The collected data cover 76% of all unique PubMed Medical Subject Headings descriptors. No systematic biases were observed across different experience levels, research fields or time spent on annotations. More importantly, annotations of the same document pairs contributed by different scientists were highly concordant. We further show that the three representative baseline methods used to generate recommended articles for evaluation (Okapi Best Matching 25, Term Frequency-Inverse Document Frequency and PubMed Related Articles) had similar overall performances. Additionally, we found that these methods each tend to produce distinct collections of recommended articles, suggesting that a hybrid method may be required to completely capture all relevant articles. The established database server located at https://relishdb.ict.griffith.edu.au is freely available for the downloading of annotation data and the blind testing of new methods. We expect that this benchmark will be useful for stimulating the development of new powerful techniques for title and title/abstract-based search engines for relevant articles in biomedical research.Peer reviewe
Does upregulated host cell receptor expression provide a link between bacterial adhesion and chronic respiratory disease?
Abstract
Expression of the platelet-activating factor receptor is upregulated in the respiratory epithelium of smokers and
chronic obstructive pulmonary disease patients. We have recently determined that increased expression of PAFr cor
-
relates with higher levels of adhesion to human bronchial epithelial cells by non-typable
Haemophilus influenzae
and
Streptococcus pneumoniae
which are major bacterial pathogens in acute exacerbations of COPD. In addition, we found
that a PAFr antagonist decreased the adhesion of both respiratory bacterial pathogens to non-cigarette exposure con
-
trol levels. This highlights the possibility that epithelial receptors, that are upregulated in response to cigarette smoke,
could be targeted to specifically block chronic bacterial infections of the lower respiratory tract. In this commentary,
we explore the question of whether adhesion to a temporally-upregulated host receptor is a common event in
chronic bacterial disease, and as such, could represent a putative therapeutic target for blocking infection by respira-
tory and other pathogens
Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in New Zealand
Extensively drug-resistant (XDR) tuberculosis has now been described in >90 countries worldwide. The first case of XDR tuberculosis (XDR-TB) in New Zealand was recorded in 2010. We report the draft whole-genome sequence of the New Zealand isolate, NZXDR1, and describe a number of single-nucleotide polymorphisms that relate to drug resistance
Tuberculosis incidence in the Irish Traveller population in Ireland from 2002 to 2013.
The health status of the Irish Traveller ethnic minority is low compared to the general population
in Ireland in terms of infant mortality rates and life expectancies. Respiratory disease is an area
of health disparity manifested as excess mortalities in Traveller males and females. In this study,
we examined the available data with regard to tuberculosis (TB) notifications in Ireland from
2002 to 2013. We found an increase in TB notifications in Irish Travellers from 2010 onwards.
This resulted in a crude incidence rate for TB in Irish Travellers that was about threefold higher
than that of the white Irish-born population in 2011 and 2012. An outbreak of TB in Irish
Travellers in 2013 increased this differential further, but when outbreak-linked cases were
excluded, a higher incidence rate was still observed in Irish Travellers relative to the general
population and to white Irish-born. The mean age of a TB patient was 26 years in Irish
Travellers compared to 43 years in the general population, and 49 years in white Irish-born.
Based on available data, Irish Travellers exhibit a higher incidence rate and younger age
distribution of TB compared to white Irish-born and the general population. These observations
emphasize the importance of routine use of ethnicity identifiers in the management of TB and
other notifiable communicable illnesses in Ireland. They also have implications for the orientation
of preventive services to address health disparities in Irish Travellers and other ethnic minority
groups
Draft Genome Sequence of a Multidrug-Resistant New Zealand Isolate of Mycobacterium tuberculosis Lineage 3.
Multidrug resistance constitutes a threat worldwide to the management of tuberculosis (TB). We report the draft whole-genome sequence of a lineage 3 (East-African Indian) isolate of Mycobacterium tuberculosis which presented as multidrug resistant in New Zealand, and describe a number of single-nucleotide polymorphisms in genes relating to drug resistance
Aerosol-mediated delivery of aav2/6-iκbα attenuates lipopolysaccharide-induced acute lung injury in rats
Inhibition of the proinflammatory transcription factor NF-kappa B has previously been shown to attenuate the inflammatory response in tissue after injury. However, the feasibility and efficacy of aerosolized adeno-associated viral (AAV) vector-delivered transgenes to inhibit the NF-kappa B pathway are less clear. Initial studies optimized the AAV vector for delivery of transgenes to the pulmonary epithelium. The effect of repeated nebulization on the integrity and transduction efficacy of the AAV vector was then examined. Subsequent in vivo studies examined the efficacy of aerosolized rAAV2/6 overexpressing the NF-kappa B inhibitor I kappa B alpha in a rodent endotoxin-induced lung injury model. Initial in vitro investigations indicated that rAAV2/6 was the most effective vector to transduce the lung epithelium, and maintained its integrity and transduction efficacy after repeated nebulization. In our in vivo studies, animals that received aerosolized rAAV2/6-I kappa B alpha demonstrated a significant increase in total I kappa B alpha levels in lung tissue relative to null vector-treated animals. Aerosolized rAAV2/6-I kappa B alpha attenuated endotoxin-induced bronchoalveolar lavage-detected neutrophilia, interleukin-6 and cytokine-induced neutrophil chemoattractant-1 levels, as well as total protein content, and decreased histologic indices of injury. These results demonstrate that aerosolized AAV vectors encoding human I kappa B alpha significantly attenuate endotoxin-mediated lung injury and may be a potential therapeutic candidate in the treatment of acute lung injury
EIRSAT-1 - The Educational Irish Research Satellite
The 2nd Symposium on Space Educational Activities (SSEA), Budapest, Hungary, 11-13 April 2018The Educational Irish Research Satellite, "EIRSAT-1", is a collaborative space project that aims to build, launch and operate the first ever Irish satellite. The EIRSAT-1 spacecraft is a 2U CubeSat incorporating three novel experiment payloads: GMOD, a gamma-ray detector; EMOD, a thermal management coating demonstration; and WBC, an attitude control algorithm. The spacecraft is currently under construction at University College Dublin and will be delivered to ESA in late 2019.Enterprise IrelandEuropean Space AgencyIrish Research CouncilUniversity College DublinENIBOIDEASSensL.Department of Business, Enterprise and Innovatio